Sharescart Research Club logo

Key Financials Snapshot

TTM · Standalone · ₹ in Cr
Market Cap
₹15058 Cr.
Stock P/E
70.5
P/B
4.7
Current Price
₹82.4
Book Value
₹ 17.4
Face Value
10
52W High
₹92.9
52W Low
₹ 67.5
Dividend Yield

Niva Bupa Health Ins Overview

Company Name: Niva Bupa Health Insurance Company Ltd.

Ticker: NIVABUPA

Country: India

Sector: Insurance

Industry: Insurance

1. Business Overview

Niva Bupa Health Insurance Company Ltd. is a specialized health insurance provider in India. The company offers a range of health insurance products, including individual, family floater, critical illness, and corporate group policies. Its core business model involves underwriting health insurance policies, collecting premiums, and managing claims. The company makes money primarily through premiums collected from policyholders, net of claims paid and operating expenses, supplemented by investment income generated from the float (funds held before claims are paid out).

2. Key Segments / Revenue Mix

Niva Bupa's primary business segments revolve around different types of health insurance policies. While specific revenue percentages are not publicly disclosed without financial reports, the main categories include:

Individual Health Insurance: Policies sold to individual customers.

Family Floater Health Insurance: Policies covering multiple family members under a single sum insured.

Group / Corporate Health Insurance: Policies provided to employer groups or organizations for their employees.

3. Industry & Positioning

The Indian health insurance industry is characterized by significant growth potential, driven by low penetration, rising healthcare costs, and increasing health awareness. It is a competitive landscape comprising public sector insurers, private general insurers, and specialized health insurers. Niva Bupa is one of the leading specialized standalone health insurers in India, known for its focus purely on health products. It positions itself on comprehensive coverage, strong customer service, and an extensive cashless hospital network, differentiating itself from general insurers who offer a wider product portfolio.

4. Competitive Advantage (Moat)

Specialization: As a standalone health insurer, Niva Bupa possesses deep expertise and focus solely on health insurance products, leading to tailored offerings and potentially better claims management.

Brand Recognition: An established brand name, benefiting from its long-standing presence and association (previously Max Bupa) and the international repute of Bupa.

Extensive Network: A wide network of cashless hospitals and healthcare providers across India, enhancing convenience for policyholders.

Customer Service & Innovation: Often cited for its customer-centric approach, product innovation, and digital initiatives to streamline policy purchase and claims.

Joint Venture Strength: The partnership with Bupa (a global healthcare leader) provides access to international best practices, operational expertise, and capital, while the Indian partner (Manipal Group) offers local market understanding and distribution reach.

5. Growth Drivers

Underpenetration: India's low health insurance penetration rates offer a substantial long-term growth runway.

Rising Healthcare Costs: Increasing medical inflation and cost of treatments compel individuals and families to seek health insurance.

Health Awareness: Growing awareness about health and wellness, significantly boosted by events like the COVID-19 pandemic, is driving demand.

Digital Adoption: Increasing digitalization makes it easier for customers to purchase policies, manage claims, and access services.

Expanding Distribution: Continued expansion into Tier 2/3 cities and leveraging digital channels will tap into new customer segments.

Government Initiatives: Schemes like Ayushman Bharat are raising overall awareness and setting benchmarks for health coverage.

6. Risks

Intense Competition: The presence of numerous public and private insurers leads to pricing pressures and challenges in market share acquisition.

High Claims Ratio: Unforeseen medical events, pandemics, and medical inflation can lead to higher-than-expected claims payouts, impacting profitability.

Regulatory Changes: Changes in IRDAI (Insurance Regulatory and Development Authority of India) regulations concerning pricing, product features, solvency norms, or distribution can impact business operations and profitability.

Economic Downturns: Reduced disposable income during economic slowdowns may affect demand for new policies or renewals.

Investment Income Volatility: Fluctuations in financial markets can impact the investment income earned on the company's float.

Data Security: The nature of the business involves handling sensitive personal and medical data, posing risks of cyber-attacks and data breaches.

7. Management & Ownership

Niva Bupa Health Insurance is a joint venture between the Manipal Group (led by Dr. Ranjan Pai) and Bupa, a leading international healthcare group based in the UK. The Manipal Group holds a 51% stake, and Bupa holds 49%. The management team typically comprises professionals with experience in the insurance and healthcare sectors, leveraging the strategic guidance and operational expertise from both joint venture partners. This structure aims to combine global best practices with strong local market understanding.

8. Outlook

Niva Bupa is well-positioned to capitalize on the significant growth potential within India's health insurance sector, driven by increasing health awareness and rising healthcare costs. Its specialization, established brand, and extensive network provide a competitive edge. However, the company operates in a highly competitive and evolving regulatory environment, necessitating efficient claims management, continuous product innovation, and robust digital integration to maintain profitability and market share. Its ability to balance aggressive growth with prudent underwriting and operational efficiency will be critical for sustained success.

Niva Bupa Health Ins Share Price

Live · BSE / NSE · Inception: 2008
| |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Standalone · annual

Niva Bupa Health Ins Quarterly Results

#(Fig in Cr.) Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Net Sales 950 1218 1018 1213 1136 1527 1220 1422 1454 1972
Other Income 126 154 191 187 159 99 153 170 164 143
Total Income 1076 1372 1209 1400 1295 1626 1373 1592 1618 2114
Total Expenditure 1071 1215 1228 1387 1282 1420 1464 1627 1705 1773
Operating Profit 5 157 -19 13 13 206 -91 -35 -88 341
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 5 157 -19 13 13 206 -91 -35 -88 341
Provision for Tax 0 0 0 0 0 0 0 0 0 -4
Profit After Tax 5 157 -19 13 13 206 -91 -35 -88 345
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 5 157 -19 13 13 206 -91 -35 -88 345
Adjusted Earnings Per Share 0 0.9 -0.1 0.1 0.1 1.1 -0.5 -0.2 -0.5 1.9

Niva Bupa Health Ins Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 315 393 544 576 659 841 1151 1753 2663 3811 4894 6068
Other Income 18 25 34 30 170 188 233 359 499 384 430 630
Total Income 333 419 578 606 830 1030 1384 2112 3161 4196 5324 6697
Total Expenditure 438 500 493 496 744 912 1259 2066 2810 4008 5144 6569
Operating Profit -105 -81 85 110 86 117 125 45 351 188 180 127
Interest 1 2 2 2 3 4 6 10 18 26 37 0
Depreciation 12 11 12 16 16 21 22 27 32 29 25 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax -93 -68 -4 23 -48 -62 -50 -197 13 82 214 127
Provision for Tax 0 0 0 0 0 0 0 0 0 0 0 -4
Profit After Tax -93 -68 -4 23 -48 -62 -50 -197 13 82 214 131
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments -93 -68 -4 23 -48 -62 -50 -197 13 82 214 131
Adjusted Earnings Per Share -1.2 -0.8 -0 0.2 -0.5 -0.5 -0.4 -1.4 0.1 0.5 1.2 0.7

Niva Bupa Health Ins Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 170 209 233 256 262 346 577 508 831 2050 3061
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 0 0 0 0 250 250 250 250
Other Non-Current Liabilities 207 266 286 298 390 502 686 1090 1611 2228 2700
Total Current Liabilities 132 170 207 267 348 389 636 891 1184 1664 3749
Total Liabilities 509 645 726 821 999 1237 1899 2738 3877 6192 9760
Fixed Assets 30 22 32 37 30 39 46 49 52 58 66
Other Non-Current Assets 433 568 628 666 818 1070 1623 2402 3370 5459 8184
Total Current Assets 47 55 66 118 152 129 230 287 455 675 1510
Total Assets 509 645 726 821 999 1237 1899 2738 3877 6192 9760

Niva Bupa Health Ins Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 14 12 69 81 53 83 32 196 59 102 143
Cash Flow from Operating Activities -47 -2 8 15 94 107 257 338 593 813 1654
Cash Flow from Investing Activities -77 -104 -24 -43 -120 -303 -374 -761 -829 -1882 -2348
Cash Flow from Financing Activities 122 108 28 0 55 145 280 374 280 1110 771
Net Cash Inflow / Outflow -2 1 12 -28 29 -51 164 -49 43 41 78
Closing Cash & Cash Equivalent 12 13 81 53 83 32 196 146 102 143 220

Niva Bupa Health Ins Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) -1.18 -0.76 -0.04 0.25 -0.49 -0.55 -0.37 -1.4 0.08 0.48 1.17
CEPS(Rs) -1.18 -0.76 -0.04 0.25 -0.49 -0.55 -0.37 -1.4 0.08 0.48 1.17
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 2.15 2.32 2.52 2.76 2.68 3.07 4.27 3.6 5.5 12.06 16.74
Core EBITDA Margin(%) -39.01 -27.2 9.44 13.93 -12.81 -8.48 -9.36 -17.91 -5.54 -5.15 -5.1
EBIT Margin(%) -29.6 -17.42 -0.68 3.97 -7.34 -7.32 -4.32 -11.21 0.47 2.15 4.36
Pre Tax Margin(%) -29.6 -17.42 -0.68 3.97 -7.34 -7.32 -4.32 -11.21 0.47 2.15 4.36
PAT Margin (%) -29.6 -17.42 -0.68 3.97 -7.34 -7.32 -4.32 -11.21 0.47 2.15 4.36
Cash Profit Margin (%) -29.6 -17.42 -0.68 3.97 -7.34 -7.32 -4.32 -11.21 0.47 2.15 4.36
ROA(%) -59.83 -36.17 -1.66 9.34 -18.67 -20.23 -10.78 -29.5 1.37 4.85 7.61
ROE(%) -59.86 -36.21 -1.66 9.34 -18.67 -20.24 -10.78 -36.26 1.87 5.68 8.36
ROCE(%) -59.86 -36.21 -1.66 9.34 -18.67 -20.24 -10.78 -29.46 1.36 4.84 7.62
Receivable days 0 0 0 0 0 0 0 0 0 0 0
Inventory Days 0 0 0 0 0 0 0 0 0 0 0
Payable days 0 0 0 0 0 0 0 0 0 0 0
PER(x) 0 0 0 0 0 0 0 0 0 0 66.75
Price/Book(x) 0 0 0 0 0 0 0 0 0 0 4.66
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 2.47 2.25 1.67 1.56 1.44 1.32 1.15 0.77 0.53 0.47 2.92
EV/Core EBITDA(x) -7.41 -10.86 10.68 8.15 11.1 9.45 10.56 29.94 4.01 9.61 79.33
Net Sales Growth(%) 32.64 24.7 38.46 5.8 14.52 27.54 36.83 52.28 51.94 43.13 28.42
EBIT Growth(%) 29.77 26.59 94.63 721.22 -311.85 -27.21 19.19 -295.11 106.38 552.66 160.87
PAT Growth(%) 29.77 26.59 94.63 721.22 -311.85 -27.21 19.19 -295.11 106.38 552.66 160.87
EPS Growth(%) 40.57 35.38 94.79 721.22 -299.98 -10.83 32.59 -278.6 105.95 480.14 142.67
Debt/Equity(x) 0 0 0 0 0 0 0 0 0 0.12 0.08
Current Ratio(x) 0.14 0.13 0.13 0.21 0.21 0.14 0.17 0.15 0.16 0.17 0.23
Quick Ratio(x) 0.14 0.13 0.13 0.21 0.21 0.14 0.17 0.15 0.16 0.17 0.23
Interest Cover(x) 0 0 0 0 0 0 0 0 0 0 0
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0 0 0.02

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +28% +41% +42% +32%
Operating Profit CAGR -4% +59% +9%
PAT CAGR +161%
Share Price CAGR 0%
ROE Average +8% +5% -6% -14%
ROCE Average +8% +5% -5% -14%

Niva Bupa Health Ins Shareholding Pattern

Latest · Mar 2026
100% held
Promoters 55.36 %
FII 10.6 %
DII (MF + Insurance) 16.46 %
Public (retail) 44.64 %
# Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 55.9855.9855.4355.4155.3655.36
FII 8.858.910.7610.7210.3210.6
DII 9.799.6715.0315.2716.0116.46
Public 44.0244.0244.5744.5944.6444.64
Others 000000
Total 100100100100100100

Niva Bupa Health Ins Peer Comparison

Insurance Edit Columns

Niva Bupa Health Ins Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Niva Bupa Health Ins Pros & Cons

Pros

  • Company is almost debt free.

Cons

  • Company has a low return on equity of 5% over the last 3 years.
  • Stock is trading at 4.7 times its book value.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp